{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:19:51Z","timestamp":1790785191439,"version":"4.1.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T00:00:00Z","timestamp":1313452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T00:00:00Z","timestamp":1313452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1038\/nrneurol.2011.120","type":"journal-article","created":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T11:23:25Z","timestamp":1313493805000},"page":"519-527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Management of pain in multiple sclerosis: a pharmacological approach"],"prefix":"10.1038","volume":"7","author":[{"given":"Claudio","family":"Solaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Messmer Uccelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,16]]},"reference":[{"key":"BFnrneurol2011120_CR1","first-page":"135","volume-title":"Multiple Sclerosis","author":"DW Paty","year":"1999","unstructured":"Paty, D. W. & Ebers, G. C. in Multiple Sclerosis 135\u2013191 (F. A. Davis Company, Philadelphia, 1999)."},{"key":"BFnrneurol2011120_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1191\/1352458503ms957oa","volume":"9","author":"G Brichetto","year":"2003","unstructured":"Brichetto, G., Messmer Uccelli, M., Mancardi, G. L. & Solaro, C. Symptomatic medication use in multiple sclerosis. Mult. Scler. 9, 458\u2013460 (2003).","journal-title":"Mult. Scler."},{"key":"BFnrneurol2011120_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pain.2006.07.015","volume":"127","author":"O Hadjimichael","year":"2007","unstructured":"Hadjimichael, O., Kerns, R. D., Rizzo, M. A., Cutter, G. & Vollmer, T. Persistent pain and uncomfortable sensations in persons with multiple sclerosis. Pain 127, 35\u201341 (2007).","journal-title":"Pain"},{"key":"BFnrneurol2011120_CR4","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1001\/archneur.1984.04050230052017","volume":"41","author":"DB Clifford","year":"1984","unstructured":"Clifford, D. B. & Trotter, J. L. Pain in multiple sclerosis. Arch. Neurol. 41, 1270\u20131272 (1984).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2011120_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0303-8467(86)80002-6","volume":"88","author":"R Vermote","year":"1986","unstructured":"Vermote, R., Ketalaer, P. & Carlton, H. Pain in multiple sclerosis patients: a prospective study using the McGill pain questionnaire. Clin. Neurol. Neurosurg. 88, 87\u201393 (1986).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"BFnrneurol2011120_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0885-3924(87)80022-2","volume":"2","author":"MR Kassirer","year":"1987","unstructured":"Kassirer, M. R. & Osterberg, D. H. Pain in chronic multiple sclerosis. J. Pain Symptom Manage. 2, 95\u201397 (1987).","journal-title":"J. Pain Symptom Manage."},{"key":"BFnrneurol2011120_CR7","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1212\/WNL.38.12.1830","volume":"38","author":"DE Moulin","year":"1988","unstructured":"Moulin, D. E., Foley, K. M. & Ebers, G. C. Pain syndromes in multiple sclerosis. Neurology 38, 1830\u20131834 (1988).","journal-title":"Neurology"},{"key":"BFnrneurol2011120_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1600-0404.1991.tb04937.x","volume":"84","author":"E Stenager","year":"1991","unstructured":"Stenager, E., Knutsen, L. & Jensen, K. Acute and chronic pain syndromes in multiple sclerosis. Acta Neurol. Scand. 84, 197\u2013200 (1991).","journal-title":"Acta Neurol. Scand."},{"key":"BFnrneurol2011120_CR9","first-page":"26","volume":"13","author":"P Warnell","year":"1991","unstructured":"Warnell, P. The pain experience of a multiple sclerosis population: a descriptive study. Axon 13, 26\u201328 (1991).","journal-title":"Axon"},{"key":"BFnrneurol2011120_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0304-3959(94)90188-0","volume":"58","author":"CJ Archibald","year":"1994","unstructured":"Archibald, C. J.  et al. Pain prevalence, severity and impact in a clinical sample of multiple sclerosis patients. Pain 58, 89\u201393 (1994).","journal-title":"Pain"},{"key":"BFnrneurol2011120_CR11","first-page":"97","volume":"16","author":"A Indaco","year":"1994","unstructured":"Indaco, A., Iachetta, C., Nappi. C., Socci, L. & Carrieri, P. B. Chronic and acute pain syndromes in patients with multiple sclerosis. Acta Neurol. 16, 97\u2013102 (1994).","journal-title":"Acta Neurol."},{"key":"BFnrneurol2011120_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/BF02230913","volume":"16","author":"E Stenager","year":"1995","unstructured":"Stenager, E., Knudsen, L. & Jensen, K. Acute and chronic pain syndromes in multiple sclerosis. Ital. J. Neurol. Sci. 16, 629\u2013632 (1995).","journal-title":"Ital. J. Neurol. Sci."},{"key":"BFnrneurol2011120_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1468-1331.2004.00815.x","volume":"1","author":"AG Beiske","year":"2004","unstructured":"Beiske, A. G., Pedersen, E. D., Czujko, B. & Myhr, K. M. Pain and sensory complaints in multiple sclerosis. Eur. J. Neurol. 1, 479\u2013482 (2004).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol2011120_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1191\/1352458503ms939oa","volume":"6","author":"DM Ehde","year":"2003","unstructured":"Ehde, D. M.  et al. Chronic pain in a large community sample of persons with multiple sclerosis. Mult. Scler. 6, 605\u2013611 (2003).","journal-title":"Mult. Scler."},{"key":"BFnrneurol2011120_CR15","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1001\/archneur.60.8.1089","volume":"60","author":"KB Svendsen","year":"2003","unstructured":"Svendsen, K. B.  et al. Pain in patients with multiple sclerosis: a population-based study. Arch. Neurol. 60, 1089\u20131094 (2003).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2011120_CR16","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1212\/01.WNL.0000137047.85868.D6","volume":"63","author":"C Solaro","year":"2004","unstructured":"Solaro, C.  et al. The prevalence of pain in multiple sclerosis. A multicenter cross-sectional study. Neurology 63, 919\u2013921 (2004).","journal-title":"Neurology"},{"key":"BFnrneurol2011120_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ejpain.2004.11.005","volume":"9","author":"A \u00d6sterberg","year":"2005","unstructured":"\u00d6sterberg, A., Boivie, J. & Thomas, K. A. Central pain in multiple sclerosis-prevalence and clinical characteristics. Eur. J. Pain 9, 531\u2013542 (2005).","journal-title":"Eur. J. Pain"},{"key":"BFnrneurol2011120_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/1352458506071346","volume":"12","author":"DM Ehde","year":"2006","unstructured":"Ehde, D. M., Osborne, T. L., Hanley, M. A., Jensen, M. P. & Kraft, G. H. The scope and nature of pain in persons with multiple sclerosis. Mult. Scler. 12, 629\u2013638 (2006).","journal-title":"Mult. Scler."},{"key":"BFnrneurol2011120_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1155\/2007\/128681","volume":"12","author":"C Piwko","year":"2007","unstructured":"Piwko, C.  et al. Pain due to multiple sclerosis: analysis of the prevalence and economic burden in Canada. Pain Res. Manag. 12, 259\u2013265 (2007).","journal-title":"Pain Res. Manag."},{"key":"BFnrneurol2011120_CR20","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.jpain.2007.03.005","volume":"8","author":"F Khan","year":"2007","unstructured":"Khan, F. & Pallant, J. Chronic pain in multiple sclerosis: prevalence, characteristics and impact on quality of life in an Australian community cohort. J. Pain 8, 614\u2013623 (2007).","journal-title":"J. Pain"},{"key":"BFnrneurol2011120_CR21","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1177\/1352458507085551","volume":"14","author":"M Boneschi","year":"2008","unstructured":"Boneschi, M.  et al. Lifetime and actual prevalence of pain and headache in multiple sclerosis. Mult Scler. 14, 514\u2013521 (2008).","journal-title":"Mult Scler."},{"key":"BFnrneurol2011120_CR22","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.apmr.2008.03.022","volume":"89","author":"C Douglas","year":"2008","unstructured":"Douglas, C., Wollin, J. & Windsor, C. Illness and demographic correlates of chronic pain among a community-based sample of people with multiple sclerosis. Arch. Phys. Med. Rehabil. 89, 1923\u20131932 (2008).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"BFnrneurol2011120_CR23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.apmr.2008.10.019","volume":"90","author":"AT Hirsh","year":"2009","unstructured":"Hirsh, A. T., Turner, A. P., Ehde, D. M. & Haselkorn, J. K. Prevalence and impact of pain in multiple sclerosis: physical and psychological contributors. Arch. Phys. Med. Rehabil. 90, 646\u2013651 (2009).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"BFnrneurol2011120_CR24","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1185\/03007990802329959","volume":"24","author":"H Moses","year":"2008","unstructured":"Moses, H. & Brandes, D. W. Managing adverse effects of disease-modifying agents used for treatment of multiple sclerosis. Curr. Med. Res. Opin. 24, 2679\u20132690 (2008).","journal-title":"Curr. Med. Res. Opin."},{"key":"BFnrneurol2011120_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2500\/108854188778607200","volume":"19","author":"BA Cohen","year":"1998","unstructured":"Cohen, B. A., Greenberg, P. A. & Saini, S. Delayed occurrence of a severe cutaneous reaction in a multiple sclerosis patient taking interferon beta-1b. Allergy Asthma Proc. 19, 85\u201388 (1998).","journal-title":"Allergy Asthma Proc."},{"issue":"Suppl. 4","key":"BFnrneurol2011120_CR26","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1212\/WNL.58.8_suppl_4.S10","volume":"58","author":"PA Calabresi","year":"2002","unstructured":"Calabresi, P. A. Considerations in the treatment of relapsing\u2013remitting multiple sclerosis. Neurology 58 (Suppl. 4), S10\u2013S22 (2002).","journal-title":"Neurology"},{"key":"BFnrneurol2011120_CR27","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1212\/WNL.53.8.1622","volume":"53","author":"EU Walther","year":"1999","unstructured":"Walther, E. U. & Hohlfeld, R. Multiple sclerosis side effects of interferon beta therapy and their management. Neurology. 53, 1622\u20131627 (1999).","journal-title":"Neurology."},{"key":"BFnrneurol2011120_CR28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1212\/WNL.48.2.332","volume":"48","author":"BS Galer","year":"1997","unstructured":"Galer, B. S. & Jensen, M. P. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 48, 332\u2013338 (1997).","journal-title":"Neurology"},{"key":"BFnrneurol2011120_CR29","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1177\/1352458507085553","volume":"14","author":"MG Grasso","year":"2008","unstructured":"Grasso, M. G.  et al. Pain in multiple sclerosis: a clinical and instrumental approach. Mult. Scler. 14, 506\u2013513 (2008).","journal-title":"Mult. Scler."},{"key":"BFnrneurol2011120_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1191\/0269215506cr880oa","volume":"20","author":"A Forbes","year":"2006","unstructured":"Forbes, A., While, A., Mathes, L. & Griffiths, P. Health problems and health-related quality of life in people with multiple sclerosis. Clin. Rehabil. 20, 67\u201378 (2006).","journal-title":"Clin. Rehabil."},{"key":"BFnrneurol2011120_CR31","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1191\/1352458505ms1168oa","volume":"11","author":"LV Kalia","year":"2005","unstructured":"Kalia, L. V. & O'Connor, P. W. Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Mult. Scler. 11, 322\u2013327 (2005).","journal-title":"Mult. Scler."},{"key":"BFnrneurol2011120_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.pain.2005.01.015","volume":"114","author":"KB Svendsen","year":"2005","unstructured":"Svendsen, K. B., Jensen, T. S., Hansen, H. J. & Bach, F. W. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain 114, 473\u2013481 (2005).","journal-title":"Pain"},{"key":"BFnrneurol2011120_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/AJP.0b013e3181891347","volume":"25","author":"B Brochet","year":"2009","unstructured":"Brochet, B.  et al. Pain and quality of life in the early stages after multiple sclerosis diagnosis: a 2-year longitudinal study. Clin. J. Pain. 25, 211\u2013217 (2009).","journal-title":"Clin. J. Pain."},{"key":"BFnrneurol2011120_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jpainsymman.2008.08.004","volume":"38","author":"RW Motl","year":"2009","unstructured":"Motl, R. W. & McAuley, E. Symptom cluster as a predictor of physical activity in multiple sclerosis: preliminary evidence. J. Pain Symptom Manage. 38, 270\u2013280 (2009).","journal-title":"J. Pain Symptom Manage."},{"key":"BFnrneurol2011120_CR35","first-page":"89","volume":"58","author":"SA Aicher","year":"2004","unstructured":"Aicher, S. A., Silverman, M. B., Winkler, C. W. & Bebo, B. F. Hyperalgesia in an animal model of multiple sclerosis. Pain 58, 89\u201393 (2004).","journal-title":"Pain"},{"key":"BFnrneurol2011120_CR36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.pain.2008.11.002","volume":"141","author":"CJ Olechowski","year":"2009","unstructured":"Olechowski, C. J., Troung, J. J. & Kerr, B. J. Neuropathic pain behaviours in a chronic\u2013relapsing model of experimental autoimmune encephalomyelitis. Pain 141, 156\u2013164. (2009).","journal-title":"Pain"},{"key":"BFnrneurol2011120_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.pain.2007.07.007","volume":"136","author":"J Lynch","year":"2008","unstructured":"Lynch, J., Gallus, N., Ericson, M. & Beitz, A. Analysis of nociception, sex and peripheral nerve innervations in the TMEV animal model of multiple sclerosis. Pain 136, 293\u2013304 (2008).","journal-title":"Pain"},{"key":"BFnrneurol2011120_CR38","doi-asserted-by":"crossref","unstructured":"Saarto, T. & Wiffen, P. J. Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD005454 doi:10.1002\/14651858.CD005454.pub2 (2007).","DOI":"10.1002\/14651858.CD005454.pub2"},{"key":"BFnrneurol2011120_CR39","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10072-004-0362-9","volume":"25","author":"C Solaro","year":"2005","unstructured":"Solaro, C., Brichetto, G., Battaglia, M. A., Messmer Uccelli, M. & Mancardi, G. L. Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study. Neurol. Sci. 25, 307\u2013310 (2005).","journal-title":"Neurol. Sci."},{"key":"BFnrneurol2011120_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1001\/archneur.1968.00480020015001","volume":"19","author":"JM Killian","year":"2001","unstructured":"Killian, J. M. & Fromm, G. H. Carbamazepine in the treatment of neuralgia: use and side effects. Arch. Neurol. 19, 129\u2013136 (2001).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2011120_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1212\/WNL.53.2.433","volume":"53","author":"C Cianchetti","year":"1999","unstructured":"Cianchetti, C., Zuddas, A., Randazzo, A. P., Perra, L. & Marrosu, M. G. Lamotrigine adjunctive therapy in painful phenomena in MS: preliminary observations. Neurology 53, 433 (1999).","journal-title":"Neurology"},{"key":"BFnrneurol2011120_CR42","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.clinthera.2007.09.023","volume":"29","author":"B Breuer","year":"2007","unstructured":"Breuer, B.  et al. Randomized double-blind, placebo-controlled two period crossover pilot trial of lamotrigine in patients with central pain due to multiple sclerosis. Clin. Ther. 29, 2022\u20132030 (2007).","journal-title":"Clin. Ther."},{"key":"BFnrneurol2011120_CR43","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/135245859700300407","volume":"3","author":"MK Houtchens","year":"1997","unstructured":"Houtchens, M. K., Richert, J. R., Sami, A. & Rose, J. W. Open label gabapentin treatment for pain in multiple sclerosis. Mult. Scler. 3, 250\u2013253 (1997).","journal-title":"Mult. Scler."},{"key":"BFnrneurol2011120_CR44","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1468-1331.2008.02496.x","volume":"16","author":"S Rossi","year":"2009","unstructured":"Rossi, S.  et al. Effects of Levetiracetam on chronic pain in multiple sclerosis: results of a randomized placebo-controlled study. Eur. J. Neurol. 16, 360\u2013366 (2009).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol2011120_CR45","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s00415-009-5203-6","volume":"256","author":"C Solaro","year":"2009","unstructured":"Solaro, C., Boemker, M. & Tanganelli, P. Pregabalin for treating paroxysmal symptoms in multiple sclerosis: a pilot study. J. Neurol. 256, 1773\u20131774 (2009).","journal-title":"J. Neurol."},{"key":"BFnrneurol2011120_CR46","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/01.wnf.0000265979.03198.33","volume":"32","author":"C Solaro","year":"2009","unstructured":"Solaro, C. & Tanganelli, P. Acute delirium in patients with multiple sclerosis treated with pregabalin. Clin. Neuropharmacol. 32, 236\u2013237 (2009).","journal-title":"Clin. Neuropharmacol."},{"key":"BFnrneurol2011120_CR47","first-page":"189","volume":"97","author":"A Dario","year":"2007","unstructured":"Dario, A. & Tomei, G. Management of spasticity in multiple sclerosis by intrathecal baclofen. Acta Neurochir. Suppl. 97, 189\u2013192 (2007).","journal-title":"Acta Neurochir. Suppl."},{"key":"BFnrneurol2011120_CR48","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/00002508-199212000-00008","volume":"8","author":"RM Herman","year":"1992","unstructured":"Herman, R. M., D'Luzansky, S. C. & Ippolito, R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin. J. Pain. 8, 338\u2013345 (1992).","journal-title":"Clin. J. Pain."},{"key":"BFnrneurol2011120_CR49","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s00415-007-0566-z","volume":"254","author":"S Sadiq","year":"2007","unstructured":"Sadiq, S. & Poopatana, C. Intrathecal basclofen and morphine in multiple sclerosis patients with severe pain and spasticity. J. Neurol. 254, 1464\u20131465 (2007).","journal-title":"J. Neurol."},{"key":"BFnrneurol2011120_CR50","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1053\/eujp.2001.0307","volume":"6","author":"S Kalman","year":"2002","unstructured":"Kalman, S., \u00d6sterberg, A., S\u00f6rensen, J., Boivie, J. & Bertler, A. Morphine responsiveness in a group of well-defined multiple sclerosis patients: a study with i.v. morphine. Eur. J. Pain. 6, 69\u201380 (2002).","journal-title":"Eur. J. Pain."},{"key":"BFnrneurol2011120_CR51","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0022-510X(98)00322-0","volume":"162","author":"M Sakurai","year":"1999","unstructured":"Sakurai, M. & Kanazawa, I. Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine. J. Neurol. Sci. 162, 162\u2013168 (1999).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol2011120_CR52","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/bmj.38149.566979.AE","volume":"329","author":"KB Svendsen","year":"2004","unstructured":"Svendsen, K. B., Jensen, T. S. & Bach, F. W. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ 329, 253 (2004).","journal-title":"BMJ"},{"key":"BFnrneurol2011120_CR53","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1477-7525-3-16","volume":"18","author":"A Solari","year":"2005","unstructured":"Solari, A. Role of health-related quality of life measures in the routine care of people with multiple sclerosis. Health Qual. Life Outcomes 18, 16 (2005).","journal-title":"Health Qual. Life Outcomes"},{"key":"BFnrneurol2011120_CR54","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.clinthera.2007.09.013","volume":"29","author":"DJ Rog","year":"2007","unstructured":"Rog, D. J., Nurmikko, T. J. & Young, C. A. Oromucosal delta9-tetrahydrocannabinol\/ cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. Clin. Ther. 29, 2068\u20132079 (2007).","journal-title":"Clin. Ther."},{"key":"BFnrneurol2011120_CR55","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0140-6736(03)14738-1","volume":"362","author":"J Zajicek","year":"2003","unstructured":"Zajicek, J.  et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet. 362, 1517\u20131526 (2003).","journal-title":"Lancet."},{"key":"BFnrneurol2011120_CR56","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","volume":"10","author":"DT Wade","year":"2004","unstructured":"Wade, D. T., Makela, P., Robson, P., House, H. & Bateman, C. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult. Scler. 10, 434\u2013441 (2004).","journal-title":"Mult. Scler."},{"key":"BFnrneurol2011120_CR57","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1468-1331.2008.02406.x","volume":"16","author":"N Putzki","year":"2009","unstructured":"Putzki, N.  et al. Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. Eur. J. Neurol. 16, 262\u2013267 (2009).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol2011120_CR58","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1212\/WNL.45.7.1294","volume":"45","author":"JP Hooge","year":"1995","unstructured":"Hooge, J. P. & Redekop, W. K. Trigeminal neuralgia in multiple sclerosis. Neurology 45, 1294\u20131296 (1995).","journal-title":"Neurology"},{"key":"BFnrneurol2011120_CR59","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1600-0404.1982.tb03076.x","volume":"65","author":"TS Jensen","year":"1982","unstructured":"Jensen, T. S., Rasmussen, P. & Reske-Nielsen, E. Association of trigeminal neuralgia with multiple sclerosis: clinical and pathological features. Acta Neurol. Scand. 65, 182\u2013189 (1982).","journal-title":"Acta Neurol. Scand."},{"key":"BFnrneurol2011120_CR60","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1093\/brain\/124.12.2347","volume":"124","author":"S Love","year":"2001","unstructured":"Love, S. & Coakham, H. B. Trigeminal neuralgia: pathology and pathogenesis. Brain 124, 2347\u20132360 (2001).","journal-title":"Brain"},{"key":"BFnrneurol2011120_CR61","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1259\/bjr\/65228893","volume":"83","author":"RJ Mills","year":"2010","unstructured":"Mills, R. J., Young, C. A. & Smith, E. T. Central trigeminal involvement in multiple sclerosis using high-resolution MRI at 3T. Br. J. Radiol. 83, 493\u2013498 (2010).","journal-title":"Br. J. Radiol."},{"key":"BFnrneurol2011120_CR62","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.pain.2008.12.026","volume":"143","author":"G Cruccu","year":"2009","unstructured":"Cruccu, G.  et al. Trigeminal neuralgia and pain related to multiple sclerosis. Pain 143, 186\u2013191 (2009).","journal-title":"Pain"},{"key":"BFnrneurol2011120_CR63","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1148\/radiology.175.3.2343134","volume":"175","author":"LG Hutchins","year":"1990","unstructured":"Hutchins, L. G., Harnsberger, H. R., Jacobs, J. M. & Apfelbaum, R. I. Trigeminal neuralgia (tic douloureux): MR imaging assessment. Radiology 175, 837\u2013841 (1990).","journal-title":"Radiology"},{"key":"BFnrneurol2011120_CR64","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/jnnp.33.4.528","volume":"33","author":"ML Espir","year":"1970","unstructured":"Espir, M. L. & Millac, P. Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (Tegretol). J. Neurol. Neurosurg. Psychiatry 33, 528\u2013531 (1970).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2011120_CR65","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000008192","volume":"44","author":"C Solaro","year":"2000","unstructured":"Solaro, C., Uccelli, M. M., Uccelli, A., Leandri, M. & Mancardi, G. L. Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eur. Neurol. 44, 45\u201348 (2000).","journal-title":"Eur. Neurol."},{"key":"BFnrneurol2011120_CR66","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1136\/bmj.320.7242.1113","volume":"320","author":"G Ramsaransing","year":"2000","unstructured":"Ramsaransing, G., Zwanikken, C. & De Keyser, J. Worsening of symptoms of multiple sclerosis associated with carbamazepine. BMJ 320, 1113 (2000).","journal-title":"BMJ"},{"key":"BFnrneurol2011120_CR67","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s004150070157","volume":"247","author":"M Leandri","year":"2000","unstructured":"Leandri, M.  et al. Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis. J. Neurol. 247, 556\u2013558 (2000).","journal-title":"J. Neurol."},{"key":"BFnrneurol2011120_CR68","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1212\/WNL.48.6.1714","volume":"48","author":"G Lunardi","year":"1997","unstructured":"Lunardi, G.  et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 48, 1714\u20131717 (1997).","journal-title":"Neurology"},{"key":"BFnrneurol2011120_CR69","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1212\/WNL.51.2.611","volume":"51","author":"OA Khan","year":"1998","unstructured":"Khan, O. A. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 51, 611\u2013614 (1998).","journal-title":"Neurology"},{"key":"BFnrneurol2011120_CR70","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1212\/WNL.51.2.609","volume":"51","author":"C Solaro","year":"1998","unstructured":"Solaro, C.  et al. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology 51, 609\u2013611 (1998).","journal-title":"Neurology"},{"key":"BFnrneurol2011120_CR71","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1212\/WNL.55.10.1587","volume":"55","author":"M Zvartau-Hind","year":"2000","unstructured":"Zvartau-Hind, M., Din, M. U., Gilani, A., Lisak, R. P. & Khan, O. A. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology 55, 1587\u20131588 (2000).","journal-title":"Neurology"},{"key":"BFnrneurol2011120_CR72","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0885-3924(01)00275-5","volume":"21","author":"C Solaro","year":"2001","unstructured":"Solaro, C., Uccelli, M. M., Brichetto, G., Gasperini, C. & Mancardi, G. L. Topiramate relieves idiopathic and symptomatic trigeminal neuralgia. J. Pain Symptom Manage. 21, 367\u2013368 (2001).","journal-title":"J. Pain Symptom Manage."},{"key":"BFnrneurol2011120_CR73","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1212\/WNL.45.6.1097","volume":"45","author":"AT Reder","year":"1995","unstructured":"Reder, A. T. & Arnason, B. Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue. Neurology 45, 1097\u20131100 (1995).","journal-title":"Neurology"},{"key":"BFnrneurol2011120_CR74","doi-asserted-by":"crossref","unstructured":"DMKG study group. Misoprostol in the treatment of trigeminal neuralgia associated with multiple sclerosis. J. Neurol. 250, 542\u2013545 (2003).","DOI":"10.1007\/s00415-003-1032-1"},{"key":"BFnrneurol2011120_CR75","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","volume":"17","author":"N Attal","year":"2010","unstructured":"Attal, N.  et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur. J. Neurol. 17, 1113\u2013e88 (2010).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol2011120_CR76","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1600-0404.1989.tb03890.x","volume":"80","author":"B Linderoth","year":"1989","unstructured":"Linderoth, B. & Hakanson, S. Paroxysmal facial pain in disseminated sclerosis treated by retrogasserian glycerol injection. Acta Neurol. Scand. 80, 341\u2013346 (1989).","journal-title":"Acta Neurol. Scand."},{"key":"BFnrneurol2011120_CR77","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1017\/S0317167100049076","volume":"21","author":"D Kondziolka","year":"1994","unstructured":"Kondziolka, D., Lunsford, L. D. & Bissonette, D. J. Long-term results after glycerol rhizotomy for multiple sclerosis-related trigeminal neuralgia. Can. J. Neurol. Sci. 21, 137\u2013140 (1994).","journal-title":"Can. J. Neurol. Sci."},{"key":"BFnrneurol2011120_CR78","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1017\/S0317167100002626","volume":"30","author":"C Berk","year":"2003","unstructured":"Berk, C., Constantoyannis, C. & Honey, C. R. The treatment of trigeminal neuralgia in patients with multiple sclerosis using percutaneous radiofrequency rhizotomy. Can. J. Neurol. Sci. 30, 220\u2013223 (2003).","journal-title":"Can. J. Neurol. Sci."},{"key":"BFnrneurol2011120_CR79","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3171\/jns.1982.57.4.0483","volume":"57","author":"G Broggi","year":"1982","unstructured":"Broggi, G. & Franzini, A. Radiofrequency trigeminal rhizotomy in treatment of symptomatic non-neoplastic facial pain. J. Neurosurg. 57, 483\u2013486 (1982).","journal-title":"J. Neurosurg."},{"issue":"Suppl. 5","key":"BFnrneurol2011120_CR80","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3171\/jns.2002.97.supplement_5.0529","volume":"97","author":"CL Rogers","year":"2002","unstructured":"Rogers, C. L.  et al. Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis. J. Neurosurg. 97 (Suppl. 5), 529\u2013532 (2002).","journal-title":"J. Neurosurg."},{"key":"BFnrneurol2011120_CR81","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000069503","volume":"79","author":"E Huang","year":"2002","unstructured":"Huang, E.  et al. Gamma knife radiosurgery for treatment of trigeminal neuralgia in multiple sclerosis patients. Stereotact. Funct. Neurosurg. 79, 44\u201350 (2002).","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"BFnrneurol2011120_CR82","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/02688690500495067","volume":"19","author":"TC Athanasiou","year":"2005","unstructured":"Athanasiou, T. C., Patel, N. K., Renowden, S. A. & Coakham, H. B. Some patients with multiple sclerosis have neurovascular compression causing their trigeminal neuralgia and can be treated effectively with MVD: report of five cases. Br. J. Neurosurg. 19, 463\u2013468 (2005).","journal-title":"Br. J. Neurosurg."},{"key":"BFnrneurol2011120_CR83","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/jnnp.59.3.253","volume":"59","author":"JFM Meaney","year":"1995","unstructured":"Meaney, J. F. M.  et al. Association between trigeminal neuralgia and multiple sclerosis: role of magnetic resonance imaging. J. Neurol. Neurosurg. Psychiatry. 59, 253\u2013259 (1995).","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"BFnrneurol2011120_CR84","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(99)94422-7","volume":"354","author":"G Broggi","year":"1999","unstructured":"Broggi, G.  et al. Role of microvascular decompression in trigeminal neuralgia and multiple sclerosis. Lancet 354, 1878\u20131879 (1999).","journal-title":"Lancet"},{"key":"BFnrneurol2011120_CR85","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/jnnp.68.1.59","volume":"68","author":"G Broggi","year":"2000","unstructured":"Broggi, G., Ferroli, P., Franzini, A., Servello, D. & Dones, I. Microvascular decompression for trigeminal nevralgia: comments on a series of 250 cases, including 10 with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 68, 59\u201364 (2000).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2011120_CR86","first-page":"542","volume-title":"Multiple Sclerosis Therapeutics","author":"RM Kanner","year":"1999","unstructured":"Kanner, R. M. in Multiple Sclerosis Therapeutics (eds Rudick, R. & Goodkin, D) 542 (Martin Dunitz, London, 1999)."},{"key":"BFnrneurol2011120_CR87","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1191\/1352458505ms1177oa","volume":"11","author":"AH Al-Araji","year":"2005","unstructured":"Al-Araji, A. H. & Oger, J. Reappraisal of Lhermitte's sign in multiple sclerosis. Mult. Scler. 11, 398\u2013402 (2005).","journal-title":"Mult. Scler."},{"key":"BFnrneurol2011120_CR88","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1212\/WNL.54.6.1368","volume":"54","author":"A Minagar","year":"2000","unstructured":"Minagar, A. & Sheremata, W. A. Glossopharyngeal neuralgia and MS. Neurology 54, 1368\u20131370 (2000).","journal-title":"Neurology"},{"key":"BFnrneurol2011120_CR89","first-page":"129","volume-title":"Nursing Practice in Multiple Sclerosis: a Core Curriculum","author":"J Halper","year":"2006","unstructured":"Halper, J. in Nursing Practice in Multiple Sclerosis: a Core Curriculum 2nd edn (eds Halper, J.  et al.) 129\u2013132 (Demos Medical Publishing, New York, 2006)."},{"key":"BFnrneurol2011120_CR90","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pain.2007.08.024","volume":"137","author":"AB O'Connor","year":"2008","unstructured":"O'Connor, A. B., Schwid, S. R., Herrmann, D. N., Markman, J. D. & Dworkin, R. H. Pain associated with multiple sclerosis: systematic review and proposed classification. Pain 137, 96\u2013111 (2008).","journal-title":"Pain"},{"key":"BFnrneurol2011120_CR91","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/135245850000600310","volume":"6","author":"C Solaro","year":"2000","unstructured":"Solaro, C., Uccelli, M. M., Guglieri, P., Uccelli, A. & Mancardi, G. L. Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis. Mult. Scler. 6, 192\u2013193 (2000).","journal-title":"Mult. Scler."},{"key":"BFnrneurol2011120_CR92","first-page":"341","volume":"75","author":"C Solaro","year":"2004","unstructured":"Solaro, C. & Tanganelli, P. Tiagabine for treating painful tonic spasms in multiple sclerosis: a pilot study. J. Neurol. Neurosurg. Psychiatry 75, 341 (2004).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2011120_CR93","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1212\/01.WNL.0000080081.74117.E4","volume":"61","author":"DA Restivo","year":"2003","unstructured":"Restivo, D. A., Tinazzi, M., Patti, F., Palmeri, A. & Maimone, D. Botulinum toxin treatment of painful tonic spasms in multiple sclerosis. Neurology 61, 719\u2013720 (2003).","journal-title":"Neurology"},{"key":"BFnrneurol2011120_CR94","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00019052-199808000-00005","volume":"11","author":"AJ Thompson","year":"1998","unstructured":"Thompson, A. J. Symptomatic treatment in multiple sclerosis. Curr. Opin. Neurol. 11, 305\u2013309 (1998).","journal-title":"Curr. Opin. Neurol."},{"key":"BFnrneurol2011120_CR95","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/j.1468-2982.2008.01662.x","volume":"28","author":"A Nicoletti","year":"2008","unstructured":"Nicoletti, A.  et al. Headache and multiple sclerosis: a population-based case\u2013control study in Catania, Sicily. Cephalalgia 28, 1163\u20131169 (2008).","journal-title":"Cephalalgia"},{"key":"BFnrneurol2011120_CR96","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10072-007-0805-1","volume":"28","author":"G Vacca","year":"2007","unstructured":"Vacca, G.  et al. Multiple sclerosis and headache co-morbidity. A case\u2013control study. Neurol. Sci. 28, 133\u2013135 (2007).","journal-title":"Neurol. Sci."},{"key":"BFnrneurol2011120_CR97","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/BF00314746","volume":"237","author":"LA Rolak","year":"1990","unstructured":"Rolak, L. A. & Brown, S. Headaches and multiple sclerosis: a clinical study and review of the literature. J. Neurol. 237, 300\u2013302 (1990).","journal-title":"J. Neurol."},{"key":"BFnrneurol2011120_CR98","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1526-4610.2005.05136.x","volume":"45","author":"JR Gee","year":"2005","unstructured":"Gee, J. R., Chang, J., Dublin, A. B. & Vijayan, N. The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis. Headache 45, 670\u2013677 (2005).","journal-title":"Headache"},{"key":"BFnrneurol2011120_CR99","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jns.2006.01.015","volume":"244","author":"P Tortorella","year":"2006","unstructured":"Tortorella, P.  et al. Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis. J. Neurol. Sci. 244, 137\u2013141 (2006).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol2011120_CR100","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.1007\/s10072-008-0908-3","volume":"29","author":"V Villani","year":"2008","unstructured":"Villani, V.  et al. Primary headache and multiple sclerosis: preliminary results of a prospective study. Neurol. Sci. 29, S146\u2013S148 (2008).","journal-title":"Neurol. Sci."},{"key":"BFnrneurol2011120_CR101","doi-asserted-by":"publisher","first-page":"a2329","DOI":"10.1136\/bmj.a2329","volume":"337","author":"CW Duncan","year":"2008","unstructured":"Duncan, C. W., Watson, D. P. B. & Stein, A. Guideline Development Group. Diagnosis and management of headache in adults: summary of SIGN guideline. BMJ 337, a2329 (2008).","journal-title":"BMJ"},{"key":"BFnrneurol2011120_CR102","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1007\/s10072-009-0053-7","volume":"30","author":"L La Mantia","year":"2009","unstructured":"La Mantia, L. Headache and multiple sclerosis: clinical and therapeutic correlations. Neurol. Sci. 30, S23\u2013S26 (2009).","journal-title":"Neurol. Sci."},{"key":"BFnrneurol2011120_CR103","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1212\/WNL.59.4.636","volume":"59","author":"W P\u00f6llmann","year":"2002","unstructured":"P\u00f6llmann, W., Erasmus, L. P., Feneberg, W., Then Bergh, F. T. & Straube, A. Interferon beta but not glatiramer acetate therapy aggravates headache in MS. Neurology 59, 636\u2013639 (2002).","journal-title":"Neurology"},{"key":"BFnrneurol2011120_CR104","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1053\/apmr.2003.50028","volume":"84","author":"AK Stuifbergen","year":"2003","unstructured":"Stuifbergen, A. K., Becker, H., Blozis, S., Timmerman, G. & Kullberg, V. A randomized clinical trial of a wellness intervention for women with multiple sclerosis. Arch. Phys. Med. Rehabil. 84, 467\u2013476 (2003).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"BFnrneurol2011120_CR105","first-page":"595","volume":"16","author":"DE Stude","year":"1993","unstructured":"Stude, D. E. & Mick, T. Clinical presentation of patient with MS and response to manual chiropractic adjustive therapies. J. Manipulative Physiol. Ther. 16, 595\u2013600 (1993).","journal-title":"J. Manipulative Physiol. Ther."},{"key":"BFnrneurol2011120_CR106","first-page":"20","volume":"8","author":"TC Vardy","year":"1997","unstructured":"Vardy, T. C. Enhancing homeostasis using osteopathic techniques for multiple sclerosis. Aust. J. Osteopath. 8, 20\u201326 (1997).","journal-title":"Aust. J. Osteopath."},{"key":"BFnrneurol2011120_CR107","first-page":"267","volume":"102","author":"HA Yates","year":"2002","unstructured":"Yates, H. A., Vardy, T. C., Kuchera, M. L., Ripley, B. D. & Johnson, J. C. Effects of osteopathic manipulative treatment and concentric and eccentric maximal effort exercise on women with multiple sclerosis: a pilot study. J. Am. Osteopathic Assoc. 102, 267\u2013275 (2002).","journal-title":"J. Am. Osteopathic Assoc."},{"key":"BFnrneurol2011120_CR108","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0163-8343(00)00100-6","volume":"22","author":"N Mills","year":"2000","unstructured":"Mills, N. & Allen, J. Mindfulness of movement as a coping strategy in multiple sclerosis. A pilot study. Gen. Hosp. Psychiatry 22, 425\u2013431 (2000).","journal-title":"Gen. Hosp. Psychiatry"},{"key":"BFnrneurol2011120_CR109","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/j.1468-1331.2007.01903.x","volume":"14","author":"FS Lienau","year":"2007","unstructured":"Lienau, F. S., F\u00fcllgraf, H., Moser, A. & Feuerstein, T. J. Why do cannabinoids not show consistent effects as analgesic drugs in multiple sclerosis? Eur. J. Neurol. 14, 1162\u20131169 (2007).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol2011120_CR110","first-page":"135","volume":"29","author":"RA Marrie","year":"2010","unstructured":"Marrie, R. A., Horwitz, R. I., Cutter, G., Tyry, T. & Vollmer, T. Association between comorbidity and clinical characteristics of MS. Acta Neurol. Scand. 29, 135\u2013141 (2010).","journal-title":"Acta Neurol. Scand."},{"key":"BFnrneurol2011120_CR111","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1097\/00002508-200006001-00017","volume":"16","author":"JA Haythornthwaite","year":"2000","unstructured":"Haythornthwaite, J. A. & Benrud-Larsen, L. M. Psychological aspects of neuropathic pain. Clin. J. Pain. 16, S101\u2013S105 (2000).","journal-title":"Clin. J. Pain."},{"key":"BFnrneurol2011120_CR112","first-page":"6","volume-title":"Pain Management Secrets","author":"R Duarte","year":"2003","unstructured":"Duarte, R. in Pain Management Secrets (ed. Kanner, R.) 6 (Hanley & Belfus, Philadelphia, 2003)."},{"key":"BFnrneurol2011120_CR113","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/nm.2249","volume":"16","author":"JT Farrar","year":"2010","unstructured":"Farrar, J. T. Advances in clinical research methodology for pain clinical trials. Nat. Med. 16, 1284\u20131293 (2010).","journal-title":"Nat. Med."},{"key":"BFnrneurol2011120_CR114","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0304-3959(98)00138-9","volume":"79","author":"S Grond","year":"1999","unstructured":"Grond, S.  et al. Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain 79, 15\u201320 (1999).","journal-title":"Pain"},{"key":"BFnrneurol2011120_CR115","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","volume":"70","author":"RD Treede","year":"2008","unstructured":"Treede, R. D.  et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70, 1630\u20131635 (2008).","journal-title":"Neurology"},{"key":"BFnrneurol2011120_CR116","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/nur.4770130405","volume":"13","author":"ME Wewers","year":"1990","unstructured":"Wewers, M. E. & Lowe, N. K. A critical review of visual analogue scales in the measurement of clinical phenomena. Res. Nurs. Health 13, 227\u2013236 (1990).","journal-title":"Res. Nurs. Health"},{"key":"BFnrneurol2011120_CR117","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jpainsymman.2006.03.008","volume":"32","author":"TL Osborne","year":"2006","unstructured":"Osborne, T. L., Raichle, K. A., Jensen, M. P., Ehde, D. M. & Kraft, G. The reliability and validity of pain interference measures in persons with multiple sclerosis. J. Pain Symptom Manage. 32, 217\u2013229 (2006).","journal-title":"J. Pain Symptom Manage."},{"key":"BFnrneurol2011120_CR118","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b","volume":"65","author":"DJ Rog","year":"2005","unstructured":"Rog, D. J., Nurmikko, T. J., Friede, T. & Young, C. A. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 65, 812\u2013819 (2005).","journal-title":"Neurology"},{"key":"BFnrneurol2011120_CR119","first-page":"S353","volume":"25","author":"CV Granger","year":"2004","unstructured":"Granger, C. V. Clinical measures of disability in multiple sclerosis patients. Neurol. Sci. 25, S353\u2013S354 (2004).","journal-title":"Neurol. Sci."},{"key":"BFnrneurol2011120_CR120","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF00541514","volume":"5","author":"GB Langley","year":"1985","unstructured":"Langley, G. B. & Shepperd, H. The visual analogue scale: its use in pain measurement. Rheumatol. Int. 5, 145\u2013148 (1985).","journal-title":"Rheumatol. Int."},{"key":"BFnrneurol2011120_CR121","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/AJP.0b013e31805d0c5d","volume":"23","author":"DJ Rog","year":"2007","unstructured":"Rog, D. J., Nurmikko, T. J., Friede, T. & Young, C. A. Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosis. Clin. J. Pain. 23, 473\u2013481 (2007).","journal-title":"Clin. J. Pain."},{"key":"BFnrneurol2011120_CR122","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/135245859900500410","volume":"5","author":"JS Fischer","year":"1999","unstructured":"Fischer, J. S.  et al. Recent developments in the assessment of quality of life in multiple sclerosis. Mult. Scler. 5, 251\u2013259 (1999).","journal-title":"Mult. Scler."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2011.120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2011.120","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2011.120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T12:19:42Z","timestamp":1650370782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2011.120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,16]]},"references-count":122,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["BFnrneurol2011120"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2011.120","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,16]]},"assertion":[{"value":"16 August 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}